摘要
目的分析无创BiPAP通气对急性心肌梗死合并心源性肺水肿的治疗效果。方法将38例急性心肌梗死合并急性肺水肿(KILLIPⅡ～KILLIPⅢ级)患者,随机分组,治疗组20例,对照组18例,均常规急性心肌梗死及抗心力衰竭治疗,治疗组予以BiPAP治疗,分别观察两组治疗后患者临床症状、心率、呼吸频率、收缩压、舒张压、动脉血气氧分压、氧饱和度变化进行临床分析。结果 20例无创BiPAP通气治疗组患者临床症状明显改善,治疗总有效率为95%,高于对照组的72.2%(P<0.05),心率、呼吸频率、收缩压、动脉血气氧分压、氧饱和度等都较对照组改善(P<0.05)。结论无创BiPAP通气通过各种机制能迅速有效改善急性心肌梗死合并肺水肿的临床症状、心率、呼吸、动脉血气分析等指标,早期应用疗效明确,可靠,值得推广应用。
Objective To evaluate the clinical effects of bilevel positive airway pressure（BiPAP） noninvasive ventilation on acute cardiogenic pulmonary edma.Methods 38 patients with acute cardiogenic pulmonary edma were included in the study.18 cases were the control group.20 cases were received BiPAP noninvasive ventilation therapy.The values of parameters,heart rate（HR）,respiratory rate（RR）,the systolic blood pressure（SBP）,arterial oxygen saturation（SpO2）,pH,arterial partial pressure of oxygen（PaO2） were measured before and after treatment.Results The HR,RR,SpO2,PaO2 after BiPAP noninvasive ventilation were improved obviously（P0.05）.The total effective rate was 95%.Conclusion BiPAP noninvasive ventilation is one of the important means to rescue actue pulmonary edma.The technique was worthy to be widely used.
出处
《中国医药指南》
2012年第17期149-150,共2页
Guide of China Medicine
